To order this detailed 720+ page report, please visit this – https://www.rootsanalysis.com/reports/view_document/gene-therapies-market/268.html
The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
Therapeutic approach
- Gene augmentation
- Oncolytic therapy
- Immunotherapy
- Others
Type of gene therapy
- Ex vivo
- In vivo
- Type of vector used
- Adeno associated virus
- Adenovirus
- Herpes simplex virus
- Lentivirus
- Plasmid DNA
- Retrovirus
- Others
Key therapeutic areas
Autoimmune disorders
Cardiovascular diseases
Dermatological disorders
Genetic disorders
Hematological disorders
Metabolic disorders
Muscle-related diseases
Oncological disorders
Ophthalmic diseases
Others
Route of administration
- Intraarticular
- Intracerebellar
- Intradermal
- Intramuscular
- Intratumoral
- Intravenous
- Intravesical
- Intravitreal
- Subretinal
- Others
Key geographical regions
North America
Europe
Asia-Pacific
To request sample pages, please visit this – https://www.rootsanalysis.com/reports/268/request-sample.html
Key Questions Answered
- Who are the leading players engaged in the development of gene therapies?
- How many gene therapies are presently being evaluated across different stages of development?
- What are various diseases targeted by gene therapies?
- What are the key technology platforms that are either available, or being developed for gene therapy discovery and production?
- What kind of vectors are commonly used for the delivery of gene therapies?
- What are the key regulatory guidelines governing the approval of gene therapies, across various geographies?
- What kind of pricing models and reimbursement strategies are currently used by gene therapy developers?
- What kind of contract services are offered related to gene therapies? Who are the key players in this market?
- What are the drivers of the M&A activity in this market?
- What kind of investors have stake in the gene therapy market?
- What kind of commercialization strategies are used by gene therapy developers?
- How is the current and future market opportunity likely to be distributed across key market segments?
You may also be interested in the following titles:
- Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (4th Edition), 2021-2030
- Global T-Cell (CAR-T, TCR, and TIL) Therapies Market (5th Edition), 2020-2030
- Oncolytic Virus Therapy Market: Pipeline Review, Developer Landscape and Competitive Insights, 2020-2030
Contact Us
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
